Related Experiment Video
Updated: Dec 31, 2025
10:32
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
14.0K
Platelet-derived bio-products: Classification update, applications, concerns and new perspectives
Andrea Acebes-Huerta1, Tamara Arias-Fernández1, Ángel Bernardo2
1Platelet Research Lab, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Summary
Platelet-derived bio-products show promise for tissue regeneration across various medical fields. Standardizing their preparation and assessment is crucial for interpreting clinical outcomes and advancing their use.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Biomaterials
Background:
- Platelet-derived bio-products, including platelet-rich plasma (PRP) and plasma-free platelet releasates, are investigated for tissue regeneration.
- Applications span traumatology, maxillofacial surgery, ophthalmology, dermatology, and otorhinolaryngology.
Purpose of the Study:
- To address the lack of consensus in the preparation, application, and quality assessment of platelet bio-products.
- To propose a classification nomenclature for improved comparison of clinical outcomes.
- To discuss current and future applications, including in vitro cell culture.
Main Methods:
- Review of current research on platelet-derived bio-products.
- Analysis of factors influencing product efficacy and clinical outcomes.
- Development of a proposed classification system.
Main Results:
- Variability in preparation and assessment methods hinders interpretation of clinical results.
- A standardized nomenclature is needed for comparing bio-products with similar characteristics.
- Platelet bio-products offer potential as alternatives to animal sera in cell culture.
Conclusions:
- Standardization of platelet bio-product preparation and quality control is essential.
- A proposed classification system can enhance comparability of clinical studies.
- Further research into standardized platelet bio-products will optimize their therapeutic potential.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
990
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
990
01:18Structure and Function of Platelets
2.7K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.7K
01:22Formation of the Platelet Plug
8.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
192
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
192